Literature DB >> 10221646

Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice.

H G Fischer1, R Dörfler, B Schade, U Hadding.   

Abstract

The influence of the intracellular parasite Toxoplasma gondii on macrophage expression of co-stimulatory molecules was studied. Unlike surface expression of CD80/B7-1, that of CD86/B7-2 is increased in mouse peritoneal macrophages 24 h following exposure to live toxoplasma in vitro. Most CD86 molecules are found on infected cells bearing a maximum parasite load. Consistent with the elevated membrane expression, the quantity of CD86 gene transcript is increased in macrophages infected by T. gondii in vitro or in vivo. CD86 up-regulation contributes to the augmented capacity of parasitized macrophages to present antigen to tuberculin-specific CD4+ T cells as demonstrated by blocking CD86 ligand interaction. T. gondii triggers up-regulation of CD86 in macrophages from BALB/c mice which are resistant to the development of toxoplasmic encephalitis. Infection of macrophages from the susceptible strain BALB.B, however, results in a decreased surface expression of CD86, although the parasite load and intracellular proliferation proved comparable in both macrophages. This differential host cell reaction correlates with disparate profiles in T. gondii-induced cytokine secretion. Upon challenge with toxoplasma, IL-1alpha and tumor necrosis factor (TNF)-alpha are released to a significantly higher extent by BALB/c than by BALB.B macrophages, whereas the latter secrete more IL-12 and IL-10. In BALB.B macrophages, T. gondii-induced IL-10 down-regulates surface expression of CD86, thus indicating an interference of parasite-dependent cytokine release and modulation of CD86. The biased secretory response in macrophages from the two congenic strains implies an MHC-dependent and dichotomous monokine induction by T. gondii. Up-regulation of CD86 seems to occur along the IL-1/TNF-inducing pathway and experimental evidence indicates that this enhances T cell activation by parasitized macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221646     DOI: 10.1093/intimm/11.3.341

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Major histocompatibility complex controls the trajectory but not host-specific adaptation during virulence evolution of the pathogenic fungus Cryptococcus neoformans.

Authors:  Erin E McClelland; Frederick R Adler; Donald L Granger; Wayne K Potts
Journal:  Proc Biol Sci       Date:  2004-08-07       Impact factor: 5.349

2.  Sepsis-induced changes in macrophage co-stimulatory molecule expression: CD86 as a regulator of anti-inflammatory IL-10 response.

Authors:  Sarah Newton; Yanli Ding; Chun-Shiang Chung; Yaping Chen; Joanne L Lomas-Neira; Alfred Ayala
Journal:  Surg Infect (Larchmt)       Date:  2004       Impact factor: 2.150

3.  The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine.

Authors:  George Hui; Caryn Hashimoto
Journal:  Vaccine       Date:  2007-10-26       Impact factor: 3.641

4.  Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts.

Authors:  George Hui; Dan Choe; Caryn Hashimoto
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

5.  miR-27b-3p, miR-181a-1-3p, and miR-326-5p are involved in the inhibition of macrophage activation in chronic liver injury.

Authors:  Weiyang Li; Na Chang; Lei Tian; Jingjing Yang; Xiaofang Ji; Jieshi Xie; Lin Yang; Liying Li
Journal:  J Mol Med (Berl)       Date:  2017-07-26       Impact factor: 4.599

6.  Toxoplasma gondii induces B7-2 expression through activation of JNK signal transduction.

Authors:  Pedro Morgado; Yi-Ching Ong; John C Boothroyd; Melissa B Lodoen
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

7.  Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice.

Authors:  Ulrike Wille; Eric N Villegas; Linden Craig; Robert Peach; Christopher A Hunter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 8.  Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!!

Authors:  Nargis Khan; Uthaman Gowthaman; Susanta Pahari; Javed N Agrewala
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.